Nafcillin

General

  • Type: Penicillin, Beta-Lactamase-Resistant Penicillin
  • Dosage Forms: IV
  • Common Trade Names: Nafcil, Nallpen

Adult Dosing

Bacterial infections

  • 0.5-2 g IV q4-6h
  • Max: 12 g/day IV; Info: dose, duration varies with infection type, severity

Osteomyelitis

  • 1-2 g IV q4h x4-6wk
  • Max: 12 g/day

Bacterial Meningitis

  • 100-200mg/kg/day IV divided q4-6h
  • Max: 12 g/day

Endocarditis, Native valve

  • 2 g IV q4h x4-6wk
  • Max: 12 g/day; Info: give with gentamicin 1mg/kg IV q8h x3-5 days

Endocarditis, Prosthetic valve

  • 2 g IV q4h x6wk
  • Max: 12 g/day; Info: give with gentamicin 1-2mg/kg IV q8h x2wk and rifampin

Renal Dosing

  • Consider decrease dose if concomitant hepatic impairment

Hepatic Dosing

  • Consider decrease dose if concomitant renal impairment

Pediatric Dosing

Bacterial Infections

  • 0-4 wk old, <1200 g
  • Dose: 50mg/kg/day IV divided q12h
  • <1 wk old, 1200-2000 g
  • Dose: 50mg/kg/day IV divided q12h
  • <1 wk old, >2000 g
  • Dose: 75mg/kg/day IV divided q8h
  • 1 wk old-1 mo, 1200-2000 g
  • Dose: 75mg/kg/day IV divided q8h
  • 1 wk old-1 mo, >2000 g
  • Dose: 100mg/kg/day IV divided q6h
  • 1 mo-16 yo
  • Dose: 50-100mg/kg/day IV divided q6h if mild-mod. infection; 100-200mg/kg/day IV divided q4-6h if severe infection; Max: 12 g/day

Endocarditis, Native valve

  • [1 mo-16 yo]
  • Dose: 200mg/kg/day IV divided q4-6h x6wk; Max: 12 g/day; Info: give with gentamicin 3mg/kg/day IV divided q8h x3-5 days

Endocarditis, Prosthetic valve

  • [1 mo-16 yo]
  • Dose: 200mg/kg/day IV divided q4-6h x6wk or longer; Max: 12 g/day; Info: give with gentamicin 3mg/kg/day IV divided q8h x2wk and rifampin

Renal Dosing

  • No adjustment unless concomitant hepatic impairment
  • CrCl 10-29: 9-25mg/kg q6h if concomitant hepatic impairment; CrCl <10: 7.5-15mg/kg q6h if concomitant hepatic impairment

Hepatic Dosing

  • Consider decrease dose if concomitant renal impairment

Safety

  • Pregnancy: Class B
  • Lactation: Probably Safe

Contraindications

  • Hypersensitivity to drug/class.
  • Anaphylactic reaction to beta-lactams
  • Caution if non-anaphylactic hypersensitivity to beta-lactams
  • Caution if hypersensitivity to multiple allergens
  • Caution if asthma or history of asthma.
  • Caution if recent antibiotic-associated colitis
  • Caution if seizure disorder
  • Caution if concomitant hepatic and renal impairment
  • Caution if sodium restriction

Adverse Reactions

Serious

  • Anaphylaxis
  • Hypersensitivity reaction, immediate or delayed
  • Serum sickness-like reaction
  • Neutropenia
  • Agranulocytosis
  • Myelosuppression
  • Clostridium difficile associated diarrhea
  • Renal tubular necrosis

Common

  • Diarrhea
  • Nausea/Vomiting
  • Utricaria
  • Pruritus
  • Rash
  • Fever
  • Eosinophilia

Pharmacology

  • Half-life: 30-90 min
  • Metabolism: Liver; CYP450:3A4 inducer
  • Excretion: bile (primarily), urine
  • Mechanism of Action: bactericidal; inhibits cell wall mucopeptide synthesis

Antibiotic Sensitivities[1]

Group Organism Sensitivity
Gram PositiveStrep. Group A, B, C, GS
Strep. PneumoniaeS
Viridans strepI
Strep. anginosus gpS
Enterococcus faecalisR
Enterococcus faeciumR
MSSAS
MRSAR
CA-MRSAR
Staph. EpidermidisS
C. jeikeiumR
L. monocytogenesR
Gram NegativesN. gonorrhoeaeR
N. meningitidisR
Moraxella catarrhalisR
H. influenzaeR
E. coliR
Klebsiella spR
E. coli/Klebsiella ESBL+R
E coli/Klebsiella KPC+R
Enterobacter sp, AmpC negR
Enterobacter sp, AmpC posR
Serratia spR
Serratia marcescensX1
Salmonella spR
Shigella spR
Proteus mirabilisR
Proteus vulgarisR
Providencia sp.R
Morganella sp.R
Citrobacter freundiiR
Citrobacter diversusR
Citrobacter sp.R
Aeromonas spR
Acinetobacter sp.R
Pseudomonas aeruginosaR
Burkholderia cepaciaR
Stenotrophomonas maltophiliaR
Yersinia enterocoliticaR
Francisella tularensisX1
Brucella sp.X1
Legionella sp.R
Pasteurella multocidaR
Haemophilus ducreyiX1
Vibrio vulnificusX1
MiscChlamydophila spR
Mycoplasm pneumoniaeR
Rickettsia spX1
Mycobacterium aviumX1
AnaerobesActinomycesR
Bacteroides fragilisR
Prevotella melaninogenicaR
Clostridium difficileX1
Clostridium (not difficile)X1
Fusobacterium necrophorumX1
Peptostreptococcus sp.S

Key

  • S susceptible/sensitive (usually)
  • I intermediate (variably susceptible/resistant)
  • R resistant (or not effective clinically)
  • S+ synergistic with cell wall antibiotics
  • U sensitive for UTI only (non systemic infection)
  • X1 no data
  • X2 active in vitro, but not used clinically
  • X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
  • X4 active in vitro, but not clinically effective for strep pneumonia

See Also

References

  1. Sanford Guide to Antimicrobial Therapy 2014
This article is issued from Wikem. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.